[A case of locally advanced rectal cancer responding to FOLFOX].

Abstract	The 57-year-old man was underwent sigmoid colostomy due to unresectable rectal carcinoma. Then he was treated with chemotherapy of levofolinate/5-fluorouracil/oxaliplatin(FOLFOX). After completion of 12 courses of chemotherapy, MR revealed responses. The patient underwent a low anterior resection. Preoperative chemotherapy with FOLFOX appears a promising regimen for patients with unresectable rectal cancer.
Authors	Shuichi Kume, Tatsuo Kubota, Masafumi Takahashi, Daisuke Hashimoto, Takafumi Hirata, Yoshitsugu Torigoe, Osamu Ikeda
Journal	Gan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 36 Issue 4 Pg. 659-61 (Apr 2009) ISSN: 0385-0684 [Print] Japan
PMID	19381043 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References	Organoplatinum Compounds Leucovorin Fluorouracil
Topics	Antineoplastic Combined Chemotherapy Protocols (therapeutic use) Fluorouracil (therapeutic use) Humans Leucovorin (therapeutic use) Magnetic Resonance Imaging Male Middle Aged Neoplasm Invasiveness (pathology) Neoplasm Staging Organoplatinum Compounds (therapeutic use) Proctoscopy Rectal Neoplasms (drug therapy, pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!